HLTH: Bridging Borders in Healthcare: Innovation, Risk, and AI with Bart Geerts
There might not be many healthcare market differences between the US and Europe, and there is a big shot for American companies in European territory.
In this episode, Lucien Engelen, CEO of TransformHealth interviews Bart Geerts, CEO of Healthcare.Plus.AI, to explore the differences, similarities, and challenges between healthcare in Europe and the United States. He discusses the role of risk management, the implications of liability, and how these factors influence healthcare delivery. Bart also shares insights from his work with Health.Plus.AI, a company focused on infection risk prediction, and his experiences in the Cedars-Sinai accelerator program.
Tune in for a deep dive into the global healthcare landscape, where innovation, culture, and technology converge to shape the future of medicine!
About Bart Geerts:
Bart Geerts is the founder of Health.Plus.AI, leveraging AI to predict and manage post-surgical infections. A former physician, he now focuses on creating impactful healthcare solutions through innovation.
Things You’ll Learn:
Healthcare delivery varies significantly between Europe and the United States, influenced by differences in funding models, regulatory environments, and cultural approaches to care.
Liability and risk management play a critical role in shaping clinical decisions, often impacting the balance between innovation and patient safety.
Artificial intelligence has the potential to predict and prevent infections.
Building trust in AI solutions is essential for their adoption in clinical practice.
Companies entering new healthcare markets must adopt a strategic approach to succeed.
Resources: